Industry: Pharmaceuticals, Biotechnology
IDM is a biopharmaceutical company focused on the development of innovative products that activate the immune system to treat cancer. IDM is currently developing two types of products designed to: • Destroy cancer cells by activating innate immunity • Prevent tumor recurrence by triggering a specific adaptive immune response Our mission is to provide highly effective treatments that maintain quality of life. To date, more than 10,000 injections have been safely administered during the course of IDM clinical trials. We have demonstrated that our products have low toxicity and are well tolerated by patients. IDM has 5 products in clinical development. The most advanced, JunovanÔ, has completed a Phase III clinical trial in ( www.idm-biotech.com )
IDM S.A.
9 Parker Suite 100
Irvine, California 92618-1605
USA
Tel: (949) 470-4751
Fax: (949) 470-6470